(Total Views: 450)
Posted On: 02/20/2021 7:22:09 PM
Post# of 153872
Are The Approvals of Remdesicir & Plasma support for the theory that the FDA is influenced by Big Pharma?
Seems to me almost hilarious that Leronlimab will probably reduce deaths 35% to 45% better than SOC, which includes Remdesivir. Rem was approved first for s/c, where it has been described by most medical professionals as having no efficacy, then later approved for m/m, where it has mild efficacy.
IMO, the FDA may struggle with the EUA, but it will be granted. If one person at the FDA was making the decision, maybe a delay or denial, but because several must decide, I say we are good.
Seems to me almost hilarious that Leronlimab will probably reduce deaths 35% to 45% better than SOC, which includes Remdesivir. Rem was approved first for s/c, where it has been described by most medical professionals as having no efficacy, then later approved for m/m, where it has mild efficacy.
IMO, the FDA may struggle with the EUA, but it will be granted. If one person at the FDA was making the decision, maybe a delay or denial, but because several must decide, I say we are good.
(1)
(0)
